These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 3150521
1. [Detailed monitoring of valproic acid and phenobarbital in the treatment of epilepsy in children]. Sobaniec W, Jankowicz E, Czerwińska-Ciechan K. Neurol Neurochir Pol; 1988; 22(5):413-20. PubMed ID: 3150521 [Abstract] [Full Text] [Related]
2. [Epilepsy with myoclonic absences]. Salas Puig J, Acebes A, González C, Tuñón A, Guisasola LM, Lahoz CH. Neurologia; 1990; 5(7):242-5. PubMed ID: 2126943 [Abstract] [Full Text] [Related]
3. [Treatment of pyknoleptic petit mal epilepsy and juvenile myoclonic epilepsy with dipropyl acetate (Deprakine). A pilot study of therapy-resistant patients during control of plasma concentration]. Schroll M, Naestoft J, Lund M. Ugeskr Laeger; 1977 May 02; 139(18):1073-7. PubMed ID: 404744 [No Abstract] [Full Text] [Related]
4. [Clinical study of serum level of dipropylacetic acid sodium (Depakene) by gaschromatography (author's transl)]. Hosokawa K, Kugoh T, Otsuki S. No To Shinkei; 1977 Aug 02; 29(8):885-90. PubMed ID: 409421 [No Abstract] [Full Text] [Related]
5. Low-dose phenobarbital for epilepsy with myoclonic absences: A case report. Ito S, Nagumo K, Nishikawa A, Oguni H, Nagata S. Brain Dev; 2021 May 02; 43(5):666-668. PubMed ID: 33461850 [Abstract] [Full Text] [Related]
10. [Advantages of a single daily dose of sodium valproate in the child]. Giroud M, Couillault G, Gouyon JB, Dauvergne M, Fantino M, Nivelon JL. Arch Fr Pediatr; 1989 Apr 02; 46(4):255-6. PubMed ID: 2502101 [Abstract] [Full Text] [Related]
12. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin JJ, Legido A. Epileptic Disord; 2004 Dec 02; 6(4):267-70. PubMed ID: 15634623 [Abstract] [Full Text] [Related]
13. Clinical efficacy of valproic acid in relation to plasma levels. Bruni J, Wilder BJ, Willmore LJ, Villarreal HJ, Thomas M, Crawford LE. Can J Neurol Sci; 1978 Nov 02; 5(4):385-7. PubMed ID: 105796 [Abstract] [Full Text] [Related]
15. [Possible uses of Convulsofin liquid in the treatment of pediatric epilepsies]. Klepel H, Koch RD, Tzenow H. Psychiatr Neurol Med Psychol (Leipz); 1986 Mar 02; 38(3):142-7. PubMed ID: 3086910 [Abstract] [Full Text] [Related]
16. Valproate-ethosuximide combination therapy for refractory absence seizures. Rowan AJ, Meijer JW, de Beer-Pawlikowski N, van der Geest P, Meinardi H. Arch Neurol; 1983 Dec 02; 40(13):797-802. PubMed ID: 6416232 [Abstract] [Full Text] [Related]
17. A study on epileptic negative myoclonus in atypical benign partial epilepsy of childhood. Yang Z, Liu X, Qin J, Zhang Y, Bao X, Chang X, Wang S, Wu Y, Xiong H. Brain Dev; 2009 Apr 02; 31(4):274-81. PubMed ID: 18562140 [Abstract] [Full Text] [Related]
18. The therapy of benign myoclonic epilepsy in infants. Todt H, Müller D. Epilepsy Res Suppl; 1992 Apr 02; 6():137-9. PubMed ID: 1418474 [Abstract] [Full Text] [Related]
19. Drug therapy: Valproic acid. Koch-Weser J, Browne TR. N Engl J Med; 1980 Mar 20; 302(12):661-6. PubMed ID: 6766529 [No Abstract] [Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats. Reeta KH, Mehla J, Pahuja M, Gupta YK. Pharmacol Biochem Behav; 2011 Sep 20; 99(3):399-407. PubMed ID: 21641922 [Abstract] [Full Text] [Related] Page: [Next] [New Search]